X4 Pharmaceuticals Inc (XFOR) is lower by Wednesday morning, with the stock falling -3.20% in pre-market trading to 1.21. XFOR's short-term technical score of 70 indicates that the stock has traded more bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, X4 Pharmaceuticals Inc ranks higher than 80% of stocks. X4 Pharmaceuticals Inc has risen 19.05% over the past month, closing at $0.99 on August 31. During this period of time, the stock fell as low as $0.89 and as high as $1.23. XFOR has an average analyst recommendation of Strong Buy. The company has an average price target of $6.17.
XFOR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on XFOR!